Pazopanib Hydrochloride (CAS 635702-64-6)
« Back to Anti-Cancer API
Pazopanib Hydrochloride
CAS No. 635702-64-6
盐酸培唑帕尼
Chemical structure
| CAS No. | 635702-64-6 |
|---|---|
| Synonyms | 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidin-yl]amino]-2-methylbenzenesulfonamide monohydrochloride |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C21H24ClN7O2S |
| Molecular Weight | 474.0 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Pazopanib hydrochloride is a multi-kinase inhibitor of VEGFR-1/2/3, PDGFR-alpha/beta and c-Kit, supplied as the hydrochloride salt. It is used in oral tablets for advanced renal cell carcinoma and advanced soft tissue sarcoma. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Poziotinib (CAS 1092364-38-9)
- Regorafenib Hydrate (CAS 1019206-88-2)
- Ribociclib Succinate (CAS 1374639-75-4)
- Ruxolitinib Phosphate (CAS 1092939-17-7)
- 2,3-Dimethyl-2H-indazol-6-amine (CAS 444731-72-0)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 635702-64-6 · PubChem CID 11525740